NL8500531A - Farmaceutisch middel voor de therapie van psoriasis. - Google Patents
Farmaceutisch middel voor de therapie van psoriasis. Download PDFInfo
- Publication number
- NL8500531A NL8500531A NL8500531A NL8500531A NL8500531A NL 8500531 A NL8500531 A NL 8500531A NL 8500531 A NL8500531 A NL 8500531A NL 8500531 A NL8500531 A NL 8500531A NL 8500531 A NL8500531 A NL 8500531A
- Authority
- NL
- Netherlands
- Prior art keywords
- stick
- pharmaceutical agent
- form according
- dithranol
- agent
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title claims description 12
- 238000002560 therapeutic procedure Methods 0.000 title claims description 12
- NUZWLKWWNNJHPT-UHFFFAOYSA-N 1, 8, 9-Anthracenetriol Natural products C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 24
- 229960002311 dithranol Drugs 0.000 claims description 21
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 14
- 239000004202 carbamide Substances 0.000 claims description 14
- 239000008177 pharmaceutical agent Substances 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 3
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical compound C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 2
- 150000003626 triacylglycerols Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 13
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- 239000012188 paraffin wax Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 239000006071 cream Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 241001422033 Thestylus Species 0.000 description 2
- 230000002682 anti-psoriatic effect Effects 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000901 systemic toxic effect Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3413569 | 1984-04-11 | ||
| DE19843413569 DE3413569A1 (de) | 1984-04-11 | 1984-04-11 | Pharmazeutisches mittel zur psoriasis-therapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8500531A true NL8500531A (nl) | 1985-11-01 |
Family
ID=6233227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8500531A NL8500531A (nl) | 1984-04-11 | 1985-02-25 | Farmaceutisch middel voor de therapie van psoriasis. |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT401344B (de) |
| BE (1) | BE902173A (de) |
| CH (1) | CH664283A5 (de) |
| DE (1) | DE3413569A1 (de) |
| FR (1) | FR2562798B1 (de) |
| GB (1) | GB2157173B (de) |
| NL (1) | NL8500531A (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3603859A1 (de) * | 1986-02-07 | 1987-08-13 | Roehm Pharma Gmbh | Abwaschbare topische zubereitung zur therapie der psoriasis |
| ES2273904T3 (es) * | 2000-12-15 | 2007-05-16 | Intendis Gmbh | Formulaciones anhidras para el cuidado de la piel que contienen urea micronizada, y metodo para producir dichas formulaciones. |
| EP1214931A1 (de) * | 2000-12-15 | 2002-06-19 | Schering Aktiengesellschaft | Mikronisierter Harnstoff enthaltende wasserfreie Hautpflegezusammensetzung und Verfahren zur Herstellung |
| ES2355767T3 (es) * | 2006-08-28 | 2011-03-30 | Hans R. Suess | Preparación dermatológica o cosmética anhidra, con contenido en urea. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE598741A (de) * | 1961-01-02 | 1961-01-31 | ||
| GB1504007A (en) * | 1976-06-28 | 1978-03-15 | Dermal Lab Ltd | Compositions containing dithranol |
| US4291062A (en) * | 1978-06-16 | 1981-09-22 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions containing urea |
| IL65588A (en) * | 1981-07-10 | 1985-04-30 | Orion Yhtymae Oy | Pharmaceutical compositions for the treatment of skin |
| FR2524313B2 (fr) * | 1982-04-05 | 1987-04-30 | Oreal | Composition stable a l'oxydation sous forme d'une dispersion ou d'une suspension d'anthraline ou de l'un de ses derives dans un alkyl-ester d'acide gras et son utilisation dans le traitement des maladies de la peau, des ongles et du cuir chevelu |
| NZ208338A (en) * | 1983-06-09 | 1987-11-27 | Bristol Myers Co | Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant |
-
1984
- 1984-04-11 DE DE19843413569 patent/DE3413569A1/de active Granted
-
1985
- 1985-02-25 NL NL8500531A patent/NL8500531A/nl not_active Application Discontinuation
- 1985-03-20 FR FR8504109A patent/FR2562798B1/fr not_active Expired
- 1985-03-26 AT AT89185A patent/AT401344B/de not_active IP Right Cessation
- 1985-04-10 GB GB08509165A patent/GB2157173B/en not_active Expired
- 1985-04-10 CH CH153485A patent/CH664283A5/de not_active IP Right Cessation
- 1985-04-11 BE BE0/214832A patent/BE902173A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AT401344B (de) | 1996-08-26 |
| GB2157173B (en) | 1987-08-19 |
| DE3413569A1 (de) | 1985-10-24 |
| CH664283A5 (de) | 1988-02-29 |
| FR2562798B1 (fr) | 1988-07-22 |
| ATA89185A (de) | 1996-01-15 |
| GB8509165D0 (en) | 1985-05-15 |
| DE3413569C2 (de) | 1992-02-13 |
| FR2562798A1 (fr) | 1985-10-18 |
| GB2157173A (en) | 1985-10-23 |
| BE902173A (fr) | 1985-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6689339B1 (en) | Viscous compositions containing carbon dioxide | |
| US4355046A (en) | Dermatologic and cosmetic ointment base | |
| US5667800A (en) | Topical preparation containing a suspension of solid lipid particles | |
| KR102414557B1 (ko) | 마이봄샘 기능 이상의 치료에 사용하기 위한 이황화셀레늄 조성물 | |
| AU724741B2 (en) | Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators | |
| DE68912459T2 (de) | Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten. | |
| JPS61501091A (ja) | 人体の皮膚に活性医薬成分を適用するための改良されたビヒクル | |
| DE69119400T2 (de) | System auf basis einer lipidformulierung | |
| US5179086A (en) | Topical ointment | |
| DE68907335T2 (de) | Im wesentlichen aus Triglyceriden gesättigter Fettsäuren bestehende, mit einem Wirkstoff beladene Mikrogranulate und ihre äusserliche therapeutische Anwendung. | |
| AU2004222536B2 (en) | Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas | |
| CA1181345A (en) | Method for the preparation of pharmaceutical compositions for the treatment of skin | |
| Veni et al. | A review on emulgels as a novel approach for topical drug delivery | |
| US20020164389A1 (en) | Method for topical treatment of carpal tunnel syndrome | |
| RU2076699C1 (ru) | Антимастопатийная мазь "мамматон" | |
| AT401344B (de) | Verfahren zur herstellung eines pharmazeutischen mittels zur psoriasis-therapie | |
| RU2207137C2 (ru) | Крем "витус-фактор" | |
| JPS6124524A (ja) | 膜組成物 | |
| JPH072631B2 (ja) | ゲル状組成物 | |
| JPH0539225A (ja) | 外用剤 | |
| Winfield | External Preparatoins | |
| FR2547725A1 (fr) | Compositions et procede de stabilisation de l'anthraline | |
| CA2179931C (fr) | Lotion eau dans huile contenant du corticosteroide | |
| RU2778231C1 (ru) | Композиции на основе дисульфида селена для применения при лечении дисфункции мейбомиевых желёз | |
| FI66533C (fi) | Foer hudvaord avsedd farmaceutisk komposition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |